<DOC>
	<DOCNO>NCT00221780</DOCNO>
	<brief_summary>Cardiac resynchronization therapy show effective reducing symptom mortality heart failure patient . However , know importance leave ventricular pacing site . We study random order 11 different leave ventricular pacing site compare hemodynamics use pressure-volume catheter . The consequence surface ECG also assess .</brief_summary>
	<brief_title>Role Left Ventricular Pacing Site</brief_title>
	<detailed_description>Background . Cardiac resynchronization therapy show effective reducing symptom mortality heart failure patient . However , know importance leave ventricular pacing site . Design . Single-blind , monocentric , randomize cross-over study compare 11 leave ventricular pacing site random order . Intervention . Left ventricular DDD pace 11 ventricular site , prior implantation . At pace site , control hemodynamics obtain AAI pace pace rate . At pace site , 2 AV delay , short long one , assess . Eligibility criterion . Patients refer cardiac resynchronization therapy heart failure Outcomes . Hemodynamic measure use pressure-volume catheter .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Cardiomyopathy , Dilated</mesh_term>
	<criteria>Heart failure refer cardiac resynchronization therapy NYHA Class III IV Informed consent form sign Hypertension control treatment Coronary ischemia control treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>Heart failure</keyword>
	<keyword>Cardiomyopathy , dilate</keyword>
	<keyword>Coronary disease</keyword>
	<keyword>Cardiac Pacing , Artificial</keyword>
	<keyword>Hemodynamics</keyword>
	<keyword>Randomized Controlled Trials</keyword>
	<keyword>Single-Blind Study</keyword>
</DOC>